Rehak, L.; Giurato, L.; Monami, M.; Meloni, M.; Scatena, A.; Panunzi, A.; Manti, G.M.; Caravaggi, C.M.F.; Uccioli, L.
The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)—Rationale and Meta-Analysis of Observational Studies. J. Clin. Med. 2024, 13, 7230.
https://doi.org/10.3390/jcm13237230
AMA Style
Rehak L, Giurato L, Monami M, Meloni M, Scatena A, Panunzi A, Manti GM, Caravaggi CMF, Uccioli L.
The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)—Rationale and Meta-Analysis of Observational Studies. Journal of Clinical Medicine. 2024; 13(23):7230.
https://doi.org/10.3390/jcm13237230
Chicago/Turabian Style
Rehak, Laura, Laura Giurato, Matteo Monami, Marco Meloni, Alessia Scatena, Andrea Panunzi, Giada Maria Manti, Carlo Maria Ferdinando Caravaggi, and Luigi Uccioli.
2024. "The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)—Rationale and Meta-Analysis of Observational Studies" Journal of Clinical Medicine 13, no. 23: 7230.
https://doi.org/10.3390/jcm13237230
APA Style
Rehak, L., Giurato, L., Monami, M., Meloni, M., Scatena, A., Panunzi, A., Manti, G. M., Caravaggi, C. M. F., & Uccioli, L.
(2024). The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)—Rationale and Meta-Analysis of Observational Studies. Journal of Clinical Medicine, 13(23), 7230.
https://doi.org/10.3390/jcm13237230
